Ocular manifestation and generalization after ocular onset in ocular myasthenia gravis: A 5-year analysis

Ocular Myasthenia Gravis (OMG) is an autoimmune disease which causes ptosis, diplopia, or both. There is very limited information on the presenting symptoms, treatment trends, factors influencing generalization, and treatment outcome in Thai populations.
read more
, , , , , , , , ,

Ability of Alere™ HIV Combo to diagnose acute HIV infection is based mainly on HIV-1 p24 antigen detection

Alere™ HIV Combo is the only rapid and sensitive point-of-care 4th generation (antigen/antibody) HIV test newly available in Thailand which is advantageous of differentiating between positivity of antigen or antibody or both, especially in acute HIV infection (AHI). AHI in this study was defined by positive machine-based 4th generation test with measurable HIV-RNA but negative 3rd generation (IgM/IgG antibody only) tests.
read more
, , , ,

Notch 2 receptor expression and reduced cytotoxicity in MAIT cells of active pulmonary TB patients

Tuberculosis (TB) is caused by Mycobacterium tuberculosis (M.tb), resulting in significant increase in mortality rate worldwide. Immunity against M.tb consists of both innate and adaptive immunity, with emerging evidence of the role of the unconventional mucosal-associated invariant T (MAIT) cells. MAIT cells are MR1-restricted T cells that possess anti-bacterial activity, including activity in response to M.tb. To date, human studies regarding peripheral blood MAIT cell frequency and MAIT cell activity in TB patients are still controversial and most studies are cross-sectional.
read more
, , , ,

Direct healthcare cost comparison of Fluticasone propionate/Salmeterol vs Budesonide/Formoterol Maintenance And Reliever Therapy for moderate/severe asthma: Results from Thailand

Inhaled corticosteroid/long-acting β2-agonist (ICS/LABA) for moderate/severe asthma i.e. regular Fluticasone propionate/Salmeterol (FP/Salm) with as-needed short acting beta-2 agonist (SABA) or ICS/Formoterol Maintenance And Reliever Therapy (MART) are the recommended options.
read more
, , , , ,

Mepolizumab improved airway hyperresponsiveness in a patient with allergic bronchopulmonary aspergillosis

Allergic bronchopulmonary aspergillosis (ABPA) is a severe type of asthma characterized by hypersensitivity to Aspergillus fumigatus and lung infiltration with eosinophilia. The central pathogenesis of asthma is airway hyperresponsiveness (AHR), with eosinophils playing a critical role. Anti-interleukin (IL)-5 antibody therapy has been recently introduced to treat severe asthma, which reportedly inactivates and reduces eosinophil count. A recent case series highlighted the improvement in asthmatic symptoms associated with ABPA, but previous reports failed to demonstrate any improvement in AHR.
read more
, , , ,